Sign in
8-K/A

Current Report

Avalo Therapeutics, Inc. Filed Acc 0001628280-24-026140

Exhibits

  • Item 9.01 Financial statements and exhibits

From the SEC's structured data for this filing

Loading avtx-20240327.htm…